How to Save on Your Prescriptions

If you think you are paying too much for medications, it’s worth investigating. Here are ways you might be able to get the medications you need at a lower cost.

The approvals of tafamidis (Vyndamax) and tafamidis meglumine (Vyndaqel) in 2019 were a victory for patients with transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM). These new agents slow the development of heart failure and reduce the 30-month mortality rate from 43% to 30%. But at $225,000 a year, the drugs may be unaffordable for many. Medicare Part D […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access